Personalized nutrition education for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a person-centered nutrition education program designed to help adults with type 1 diabetes improve blood sugar control. It focuses on providing individual dietary guidance that fits your lifestyle and preferences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You have had diabetes for more than 1 year.
- You are 18 years or older.
- Your latest HbA1c level is above 57 mmol/mol (about 7.3%).
- You have been using a continuous glucose monitor (CGM) for more than 3 months and will continue using it during the study.
- You take both a long-acting (basal) and rapid-acting (bolus) insulin, and have been on this regimen for more than 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a personalized education program, supported by continuous glucose monitor (CGM) wear, can help adults with type 2 diabetes improve their blood sugar control. Participants will receive extra training and a CGM device to see how food, activity, and medications affect their glucose levels in real time.
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This study tests a personalized decision-support tool to help people with type 1 diabetes manage their blood sugar during exercise. It involves supervised walking sessions and wearing devices to track your glucose.
This trial tests a new way to manage type 1 diabetes by tailoring treatment based on your personal needs and glucose data. You'll share data from your continuous glucose monitor with the diabetes team at Tampere University Hospital and receive remote care instead of in-person visits.
This study tests whether a pharmacist-led education program can improve quality of life, medication adherence, and satisfaction for people with type 1 diabetes whose blood sugar is not well controlled. It is designed for Arabic-speaking adults and teens 16 and older.
Hear when a new Diabetes Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.